EMA Authorised: Levetiracetam ratiopharm (levetiracetam) — ratiopharm GmbH

View source ↗

Summary

The EMA has authorised a generic levetiracetam product (Levetiracetam ratiopharm) by ratiopharm GmbH for epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Levetiracetam ratiopharm (levetiracetam)

Snippet

Status: Authorised. Therapeutic area: Epilepsy. MAH: ratiopharm GmbH. Decision date: 22/01/2026